Table 2.
Parameter | IHC results for SRD5A2 | |||
---|---|---|---|---|
Strong positive (n, %) | Weak positive (n, %) | Negative (n, %) | P-value | |
Age | 0.357 | |||
<60 | 4 (66.67%) | 1 (16.67%) | 1 (16.67%) | |
≥60 | 22 (61.11%) | 12 (33.33%) | 2 (5.56%) | |
Envelope invasion | 0.304 | |||
No | 24 (64.86%) | 11 (29.73%) | 2 (5.41%) | |
Yes | 2 (40.00%) | 2 (40.00%) | 1 (20.00%) | |
Seminal vesicle invasion | 0.395 | |||
No | 26 (63.41%) | 12 (29.27%) | 3 (7.32%) | |
Yes | 0 (0.00%) | 1 (100.00%) | 0 (0.00%) | |
Gleason score | 0.013* | |||
≤7 | 25 (67.57%) | 11 (29.73%) | 1 (2.70%) | |
>7 | 1 (20.00%) | 2 (40.00%) | 2 (40.00%) | |
Pathology stage | 0.047* | |||
I–II | 24 (66.67%) | 11 (30.56%) | 1 (2.78%) | |
III–IV | 2 (33.33%) | 2 (33.33%) | 2 (33.33%) |
*P < 0.05.